compounding pharmacy selling semaglutide Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s FDA Warns on Certain Forms

Meshkat S, Liu Y, Jung H, Tassone VK, Pang H, Janssen-Aguilar R, et al

August 2025: Novo Nordisk announced a USD 4.1 billion U.S

Systemic infections including Epstein-Barr virus (infectious mononucleosis), cytomegalovirus, toxoplasmosis, HIV, tuberculosis, cat scratch disease (Bartonella), and certain sexually transmitted infections should be considered based on clinical context and risk factors

Those evaluating wellness programs that include structured assessments and laboratory-guided care

Another key point: stopping therapy leads to regain in most people, which argues for getting to and staying at an effective maintenance dose rather than hovering at subtherapeutic levels

Severely elevated lipase with abdominal symptoms As noted earlier, mild lipase elevation is common and benign on GLP-1 therapy